[1]王琳*,耿女,曾彬,等.血清内脂素水平与多囊卵巢综合征患者子宫内膜病理状态的关系分析[J].中国计划生育和妇产科,2020,(7):64-67.
　WANG Lin*,GENG Nv,ZENG Bin,et al.Relationship between serum visfatin level and endometrial pathological status of patients with polycystic ovary syndrome[J].Chinese Journal of Family Planning & Gynecotokology,2020,(7):64-67.
点击复制

血清内脂素水平与多囊卵巢综合征患者子宫内膜病理状态的关系分析
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2020年7期
页码:
64-67
栏目:
妇科产科热点研究
出版日期:
2020-07-25

文章信息/Info

Title:
Relationship between serum visfatin level and endometrial pathological status of patients with polycystic ovary syndrome
作者:
王琳1*; 耿女2; 曾彬2; 李翠2; 韩宝生2; 樊桂玲2
唐山市妇幼保健院,1.计划生育科;2.生殖遗传科
Author(s):
WANG Lin1*; GENG Nv2; ZENG Bin2; LI Cui2; HAN Baosheng2; FAN Guiling2
1. Department of Family Planning; 2. Department of Reproductive Genetics，Tangshan Maternal and Child Health Hospital，Tangshan Hebei 063000,P.R.China
关键词:
内脂素; 多囊卵巢综合征; 子宫内膜增生; 癌变
Keywords:
visfatin; polycystic ovary syndrome; endometrial hyperplasia; carcinogenesis
分类号:
R 71175
摘要:
目的探讨血清内脂素水平与多囊卵巢综合征（polycystic ovary syndrome，PCOS）患者子宫内膜病理状态的关系，为PCOS患者子宫内膜病变的诊断提供指导。方法选取2018年1月至2019年5月在唐山市妇幼保健院收治的PCOS患者68例，根据子宫内膜病理检查结果分为非正常子宫内膜组（n=27）和正常子宫内膜组（n=41），另选同期健康体检女性30例为对照组。比较3组一般资料及性激素、血脂、胰岛功能及内脂素水平，多因素Logistic回归分析PCOS患者子宫内膜增生及癌变的独立影响因素，利用受试者工作特征（ROC）曲线分析内脂素对PCOS患者子宫内膜病变的诊断价值。结果与对照组相比，非正常子宫内膜组、正常子宫内膜组体质量指数、腰臀比、总胆固醇、甘油三酯、空腹胰岛素（fasting insulin，FINS）、胰岛素抵抗指数（homeostasis model assessment of insulin resistance，HOMAIR）、胰岛β细胞分泌指数（islets β cell secretory index，HOMAβ）、促黄体生成素、睾酮及内脂素水平均明显增高（P<005）；与正常子宫内膜组相比，非正常子宫内膜组体质量指数、腰臀比、FINS、HOMAIR、HOMAβ及血清内脂素水平均明显增高（P<005）。多因素Logistic回归分析结果显示，FINS（OR=2125，95 % CI：10564279）、HOMAIR（OR=4811，95 % CI：197611715）、HOMAβ（OR=2396，95 % CI：13004417）及内脂素（OR=1510，95 % CI：11861921）水平均为PCOS患者发生子宫内膜增生及癌变独立危险因素（P<005）。ROC曲线分析，血清内脂素水平诊断PCOS患者子宫内膜增生及癌变的曲线下面积为0839（95 % CI：07680921）。结论血清内脂素水平是PCOS患者子宫内膜增生及癌变的独立影响因素，对PCOS患者子宫内膜病变的诊断有重要价值。
Abstract:
ObjectiveTo investigate the relationship between serum visfatin levels and endometrial pathology in patients with polycystic ovary syndrome (PCOS)，to provide guidance for diagnosis of endometrial lesions in PCOS patients.Methods68 patients with PCOS admitted to Tangshan Maternal and Child Health Hospital from January 2018 to May 2019 were enrolled. According to the results of endometrial pathology, they were divided into abnormal endometrial group (n=27) and normal endometrium group（n=41), 30 women in the same period of healthy physical examination were selected as the control group.Compared the general information and sex hormones, blood lipids, islet function and visfatin levels of 3 groups. Multivariate logistic regression analysis was used to analyze the independent influencing factors of endometrial hyperplasia and carcinogenesis in patients with PCOS. The receiver operating characteristic (ROC) curve was used to analyze the diagnostic value of visfatin for endometrial lesions in patients with PCOS.ResultsCompared with control group, body mass index, waisthip ratio, total cholesterol, triglycerides, fasting insulin (FINS), homeostasis model assessment of insulin resistance (HOMAIR), islets β cell secretory index (HOMAβ), luteinizing hormone, testosterone and visfatin levels were significantly increased in abnormal endometrial group and normal endometrial group (P<005). Compared with normal endometrium group, body mass index, waisthip ratio, FINS, HOMAIR, HOMAβ and serum visfatin level were significantly increased in abnormal endometrial group (P<005). Multivariate Logistic regression analysis showed that FINS (OR=2125, 95 % CI:10564279), HOMAIR (OR=4811, 95 % CI:197611715), HOMAβ (OR=2396,95 % CI:13004417) and visfatin (OR=1510,95 % CI:11861921) were independent risk factors for endometrial hyperplasia and carcinogenesis in PCOS patients (P<005). ROC curve analysis showed that area under the curve of serum visfatin level for diagnosis of endometrial hyperplasia and carcinogenesis in PCOS patients was 0839 (95 % CI:07680921).ConclusionSerum visfatin level is an independent influencing factor of endometrial hyperplasia and carcinogenesis in patients with PCOS, and is of great value in the diagnosis of endometrial lesions in patients with PCOS.

参考文献/References:

［1］Frossing S, Nylander M, Kistorp C, et al. Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS［J］. Endocr Connect, 2018,7(1):115123. ［2］陈军, 罗英, 周正琴. 孕中、晚期多囊卵巢综合征患者发生妊娠期糖尿病的危险因素分析 ［J］. 重庆医科大学学报, 2018,43(2):245249. ［3］闵璐, 刘逸超, 满玉晶,等. 从中医虚痰瘀角度论治多囊卵巢综合征并发子宫内膜病变 ［J］. 中国中医基础医学杂志, 2017,23(3):440442. ［4］钟银秀, 张国楠. 二甲双胍降低多囊卵巢综合征患者子宫内膜癌发生风险的研究进展 ［J］. 中华妇产科杂志, 2016, 51(8):638640. ［5］刘蓉, 张丹, 杨玲,等. 2型糖尿病患者血清脂联素和内脂素水平与糖尿病肾病的相关性 ［J］. 中国老年学杂志, 2017, 37(16):39843985. ［6］田文艳, 王颖梅, 张艳芳, 等. 脂肪因子内脂素与恶性肿瘤关系的研究现状及展望 ［J］. 中华肿瘤杂志, 2017, 39(5):321324. ［7］ESPCW Group．Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS)［J］ ．Fertility Sterility， 2004， 81(1) : 4147． ［8］沈丹华. 子宫内膜癌及癌前病变第4版WHO的分类解读 ［J］. 实用妇产科杂志, 2015, 31(7):495497. ［9］张妍, 张慧英, 宋学茹. 多囊卵巢综合征患者内脂素表达与子宫内膜病变相关性研究 ［J］. 中国计划生育学杂志, 2019, 27(1):2730. ［10］Nilgün Güdücü, Herman  �瘙 塂 i, Uzay Grmü �瘙 塂 , et al. Serum visfatin levels in women with polycystic ovary syndrome［J］. Gynecol Endocrinol, 2012, 28(8):619623. ［11］Kim J J, Choi Y M, Hong M A, et al. Serum visfatin levels in nonobese women with polycystic ovary syndrome and matched controls ［J］. Obstet Gynecol Sci, 2018, 61(2):253260. ［12］Wiweko B, Indra, Susanto, et al. The correlation between serum AMH and HOMAIR among PCOS phenotypes［J］. Bmc Res Notes, 2018, 11(1):114119. ［13］Assiri, Adel M A, Kamel, et al. Evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and visfatin in postmenopausal breast cancer ［J］. Obes Res Clin Pract, 2016, 10(4):442453. ［14］Yang J, Zhang K, Song H, et al. Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism ［J］. Oncotarget, 2016, 7(22):3230632317. ［15］Tian W, Zhu Y, Wang Y, et al. Visfatin, a potential biomarker and prognostic factor for endometrial cancer ［J］. Gynecol Oncol, 2013, 129(3):505512. ［16］殳姗姗, 哈灵侠, 赏江霞, 等. PCOS患者卵泡液中内脂素、网膜素1与IVFET的相关性研究 ［J］. 现代妇产科进展, 2018，27(3):198201. ［17］蒋文蔚, 黄学锋. 补肾健脾方治疗脾肾不足型多囊卵巢综合征疗效及对血清内脂素及hsCRP水平的影响 ［J］. 中华中医药学刊, 2016,34(6):14821485. ［18］朱亚莉，黄燕清，易丹妮，等.不同表型多囊卵巢综合征患者内脂素与内分泌代谢特征的相关性 ［J］. 广东医学,2018,39(S 2):5659，62. ［19］涂彬彬, 张秋芳，闫丽盈, 等. 多囊卵巢综合征患者子宫内膜增生相关因素的分析 ［J］. 现代妇产科进展2011,20(9):693697. ［20］陈咏健, 李美芝. 胰岛素与雄激素对多囊卵巢综合征患者子宫内膜体外生长的影响 ［J］. 中华医学杂志, 2000, 80(10):759760. ［21］Yang J, Zhang K,Song H,et al.Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism ［J］.Oncotarget,2016,7(22):3230632317. ［22］Wang Y,Gao C, Zhang Y, et al. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways ［J］. Gynecol Oncol, 2016, 143(1):168178.

相似文献/References:

[1]姜荣华,钟小英,潘萍,等.61例多囊卵巢综合征妇女行供精人工授精结局分析[J].中国计划生育和妇产科,2011,(04):0.
　JIANG Rong-hua,ZHONG Xiao-ying,PAN Ping.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(7):0.
[2]任涛,熊小英,蔡春芳,等.多囊卵巢综合征患者视黄醇结合蛋白-4的水平变化及意义[J].中国计划生育和妇产科,2013,(04):0.
　REN Tao *,XIONG Xiao-ying,CAI Chun-fang.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(7):0.
[3]龚衍,曾玖芝,李运星,等.不同剂量来曲唑对多囊卵巢综合征不孕症患者诱导排卵的临床观察[J].中国计划生育和妇产科,2013,(05):0.
　GONG Yan,ZENG Jiu-zhi,Li Yun-xing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(7):0.
[4]李琳.无生育要求多囊卵巢综合征患者无排卵的处理[J].中国计划生育和妇产科,2014,(04):0.
　LI Lin,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(7):0.
[5]刘振腾,郝翠芳.有生育要求的多囊卵巢综合征患者的治疗[J].中国计划生育和妇产科,2014,(04):0.
　LIU Zhen-teng,HAO Cui-fang,Reproductive Medical Center,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(7):0.
[6]李淑红.腹腔镜下卵巢表面电凝术治疗多囊卵巢综合征的疗效分析[J].中国计划生育和妇产科,2014,(04):0.
　LI Shu-hong,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(7):0.
[7]倪仁敏,杨冬梓.多囊卵巢综合征的发病概况[J].中国计划生育和妇产科,2014,(06):0.
[8]崔琳琳,陈子江.多囊卵巢综合征的临床诊断要点[J].中国计划生育和妇产科,2014,(06):0.
[9]刘义.多囊卵巢综合征长期管理与治疗策略[J].中国计划生育和妇产科,2014,(06):0.
[10]李尚为.多囊卵巢综合征的促排卵治疗[J].中国计划生育和妇产科,2014,(06):0.
[11]杨坤,王子豪,马晓欣.多囊卵巢综合征与子宫内膜病变关系研究进展[J].中国计划生育和妇产科,2021,(2):33.
　[J].Chinese Journal of Family Planning & Gynecotokology,2021,(7):33.

备注/Memo

备注/Memo:
河北省医学科学研究重点课题(项目编号：20181316)
更新日期/Last Update: 2020-07-25